Pedro Rondot Radio, M.D. is the Executive Director of the Public Oncologic Serum Biobank at the Institute of Oncology at the University of Buenos Aires. He received his MD at the National University of Rosario. Before his position at the institute of Oncology, he worked in training in biobank techniques at the solid tumor bank at the National Pediatric Hospital of Buenos Aires. He is involved in a range of activities relating to hemostatis and thrombosis, including patients with bleeding disorders as well as control and treatment of patients with DIC and HIT in the ICU.
Rao Mulpuri serves as a Director of Scientific Operations at the Catholic Health Initiatives (CHI's) Center for Translational Research, and provides leadership to facilitate the advancement, commercialization and integration of personalized medicine. Rao is a strategic visionary leader with a unique blend of entrepreneurial vision and business acumen, and his specialties include developing business/commercial strategies and launching new ventures (start-ups), leading business units during both the start-up and corporate transformation (Merger and Acquisition) phases, management of scientific/technical operations (Genomics, Biomarker Discovery and Validation, Personalized Medicine), quality and regulatory affairs, and technology evaluation for investments/new ventures. Prior to joining the CTR, Rao served as the Site Head of a Biomarker discovery and Clinical testing facility of Beckman Coulter Genomics (formerly Cogenics). Rao has an MBA (Honors), a PhD in life sciences and has published 36 scientific publications in peer-reviewed scientific journals, and named as an inventor on 14 patents. Rao has also received international awards (NSERC Canada International Fellow and Japan Society for the Promotion of Science (JSPS) Fellow).in recognition of his research contributions.
Zackery Riley, BSc, MBA is Manager, Tissue Procurement and Process Development at the Allen Institute for Brain Science. Mr. Riley has spent the past eight years at the Allen Institute developing tools, equipment and techniques for creating large-scale brain atlases in a high-throughput environment. Most recently, this work has included screening, procuring, processing, MRI and transport of post-mortem, fresh-frozen, human brain tissue in collaboration with brain banks and tissue repositories. He has developed novel applications and methods for dealing with these processes in collaboration with a broad range of medical, clinical, technical and legal professionals to jointly overcome these challenges.